Tesamorelin similar pathway to sermorelin, with a specific association with visceral fat reduction
the BPC peptide salts of the present invention are useful for the treatment of hypertension, angina, impotence, circulatory shock, septic shock, stroke, inflammation, respiratory distress syndromes, pulmonary hypertension, pancreatitis, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, and Parkinson's disease
Low Starting Amount Amount per injection: 200 mcg 6 units (0.06 mL) on a U-100 insulin syringe Frequency: Once daily, under the skin (subcutaneous) Cycle length: 812 weeks Inject near the target site or in the abdomen
Lyophilized powder 10mg per vial 98% purity For research purposes only Not for human consumption BPC-157 is a synthetic peptide consisting of 15 amino acids